Literature DB >> 23974777

When thyroid hormone replacement is ineffective?

Salvatore Benvenga1.   

Abstract

PURPOSE OF REVIEW: In this article, we will consider the failure of thyroid hormone replacement therapy to normalize serum thyroid stimulating hormone concentrations. We will review circumstances and causes for failures, discuss pertinent unpublished personal cases of didactical value, and provide practical suggestions for providers encountering patients with similar presentations. RECENT
FINDINGS: Recent data are available on the benefit of novel formulations of levothyroxine therapy on malabsorption.
SUMMARY: Most frequently, reasons for ineffectiveness are noncompliance, inappropriate administration of levothyroxine, gastrointestinal disorders, and drug interactions. The diagnostic work-up should include careful history to elucidate the potential reasons for the ineffective therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974777     DOI: 10.1097/MED.0000000000000003

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  30 in total

1.  Do Not Forget Nephrotic Syndrome as a Cause of Increased Requirement of Levothyroxine Replacement Therapy.

Authors:  Salvatore Benvenga; Roberto Vita; Flavia Di Bari; Poupak Fallahi; Alessandro Antonelli
Journal:  Eur Thyroid J       Date:  2015-05-28

2.  Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.

Authors:  Rosarita Ferrara; Valentina Ientile; Vincenzo Arcoraci; Carmen Ferrajolo; Carlo Piccinni; Andrea Fontana; Salvatore Benvenga; Gianluca Trifirò
Journal:  Endocrine       Date:  2017-02-02       Impact factor: 3.633

3.  Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari; Roberto Vita
Journal:  Endocrine       Date:  2017-02-03       Impact factor: 3.633

4.  Intestinal absorption and buccal absorption of liquid levothyroxine.

Authors:  Salvatore Benvenga; Flavia Di Bari
Journal:  Endocrine       Date:  2017-03-07       Impact factor: 3.633

Review 5.  Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

6.  Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Santino Marchi; Nicola De Bortoli; Ilaria Ruffilli; Alessandro Antonelli
Journal:  Endocrine       Date:  2016-08-30       Impact factor: 3.633

Review 7.  Liquid and softgel levothyroxine use in clinical practice: state of the art.

Authors:  Camilla Virili; Pierpaolo Trimboli; Francesco Romanelli; Marco Centanni
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

8.  Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Alessandro Antonelli
Journal:  Endocrine       Date:  2015-12-31       Impact factor: 3.633

9.  In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

10.  L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2018-10-27       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.